![Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch](https://www.frontiersin.org/files/Articles/773204/fphar-12-773204-HTML/image_m/fphar-12-773204-g002.jpg)
Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
![Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat - ScienceDirect Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006899319302811-gr1.jpg)
Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat - ScienceDirect
![The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS2633289221000077/resource/name/S2633289221000077_figAb.png?pub-status=live)
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
![Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch](https://www.frontiersin.org/files/Articles/773204/fphar-12-773204-HTML/image_m/fphar-12-773204-g001.jpg)
Frontiers | Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling
![β-Arrestin 1 and 2 similarly influence μ-opioid receptor mobility and distinctly modulate adenylyl cyclase activity - ScienceDirect β-Arrestin 1 and 2 similarly influence μ-opioid receptor mobility and distinctly modulate adenylyl cyclase activity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0898656821002138-ga1.jpg)
β-Arrestin 1 and 2 similarly influence μ-opioid receptor mobility and distinctly modulate adenylyl cyclase activity - ScienceDirect
![The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2017.204/MediaObjects/41386_2018_Article_BFnpp2017204_Fig1_HTML.jpg)
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain | Neuropsychopharmacology
![Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.2c00442/asset/images/large/oc2c00442_0001.jpeg)
Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science
![Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.2c00442/asset/images/medium/oc2c00442_0003.gif)
Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science
![Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor- kappa B signaling pathway Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor- kappa B signaling pathway](https://www.frontiersin.org/files/Articles/1013033/fnmol-15-1013033-HTML/image_m/fnmol-15-1013033-g001.jpg)
Frontiers | Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor- kappa B signaling pathway
![A model of the μ opioid receptor structure. Transmembrane helices are... | Download Scientific Diagram A model of the μ opioid receptor structure. Transmembrane helices are... | Download Scientific Diagram](https://www.researchgate.net/publication/228634919/figure/fig1/AS:393760606310400@1470891252127/Fig-1-A-model-of-the-m-opioid-receptor-structure-Transmembrane-helices-are-colored.png)
A model of the μ opioid receptor structure. Transmembrane helices are... | Download Scientific Diagram
![Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.2c00442/asset/images/medium/oc2c00442_0002.gif)
Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science
![IJMS | Free Full-Text | Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors IJMS | Free Full-Text | Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors](https://www.mdpi.com/ijms/ijms-24-02245/article_deploy/html/images/ijms-24-02245-g001.png)
IJMS | Free Full-Text | Cardiovascular Disease in Obstructive Sleep Apnea: Putative Contributions of Mineralocorticoid Receptors
![IJMS | Free Full-Text | β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane IJMS | Free Full-Text | β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane](https://pub.mdpi-res.com/ijms/ijms-21-04626/article_deploy/html/images/ijms-21-04626-ag.png?1602232642)
IJMS | Free Full-Text | β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane
![PDF) Asymmetric syntheses of (+)- and (–)-collybolide enable reevaluation of kappa-opioid receptor agonism PDF) Asymmetric syntheses of (+)- and (–)-collybolide enable reevaluation of kappa-opioid receptor agonism](https://i1.rgstatic.net/publication/357231937_Asymmetric_syntheses_of_-_and_--collybolide_enable_reevaluation_of_kappa-opioid_receptor_agonism/links/61c27ab852bd3c7e058332a0/largepreview.png)
PDF) Asymmetric syntheses of (+)- and (–)-collybolide enable reevaluation of kappa-opioid receptor agonism
![The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210820173929712-0645:S2633289221000077:S2633289221000077_fig2.png?pub-status=live)
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
![Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa-Opioid Receptor Agonism | ACS Central Science](https://pubs.acs.org/cms/10.1021/acscentsci.2c00442/asset/images/medium/oc2c00442_0006.gif)